Article

Soy protein for infant feeding: what do we know?

Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Lille University Children's Hospital and Faculty of Medicine, Hôpital Jeanne de Flandre, 2 avenue Oscar Lambret, 59037 Lille cedex, France.
Current Opinion in Clinical Nutrition and Metabolic Care (Impact Factor: 3.97). 06/2007; 10(3):360-5. DOI: 10.1097/MCO.0b013e3280fa821b
Source: PubMed

ABSTRACT This review discusses the safety, nutritional adequacy and recommendations for use of soy protein formulae, based mainly on the most relevant reports published during 2005 and 2006.
Concerns have recently been raised regarding potential risks with soy protein formulae, in particular regarding their high phytoestrogenic isoflavone content. Recent data are insufficient to draw definitive conclusions on safety, but authorities and paediatric societies from several countries recently advised health professionals to use soy protein formulae only in certain cases. Indications for use of soy protein formulae, mainly for prevention and management of food allergy, have also been better defined.
Soy protein formulae ensure normal growth and development in healthy term infants but they have no nutritional advantages over cow's milk protein formulae. Main indications include severe lactose intolerance, galactosaemia and need to avoid foods of animal origin. Soy protein formulae have no role in preventing allergy or in management of nonspecific gastrointestinal symptoms (e.g. infantile colic and regurgitation). They should not be used in preterm infants or infants with food allergy before age 6 months. After 6 months, soy protein formulae may be considered if tolerance to soy protein is established.

0 Followers
 · 
88 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Review of the existing literature suggests that consumption of soy foods or an exposure to a soy isoflavone genistein during childhood and adolescence in women, and before puberty onset in animals, reduces later mammary cancer risk. In animal studies, an exposure that is limited to the fetal period or adult life does not appear to have the same protective effect. A meta-analysis of human studies indicates a modest reduction in pre- and postmenopausal risk when dietary intakes are assessed during adult life. These findings concur with emerging evidence indicating that timing may be vitally important in determining the effects of various dietary exposures on the susceptibility to develop breast cancer. In this review, we address the mechanisms that might mediate the effects of an early life exposure to genistein on the mammary gland. The focus is on changes in gene expression, such as those involving BRCA1 and PTEN. It will be debated whether mammary stem cells are the targets of genistein-induced alterations and also whether the alterations are epigenetic. We propose that the effects on mammary gland morphology and signalling pathways induced by pubertal exposure to genistein mimic those induced by the oestrogenic environment of early first pregnancy.
    British Journal of Cancer 06/2008; 98(9):1485-93. DOI:10.1038/sj.bjc.6604321 · 4.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To determine clinical and follow up characteristics of children enrolled in a program to supply formulas for cow's milk allergy. descriptive study of a convenience sample composed of 214 children up to three years old, with clinical diagnosis of cow's milk allergy and/or standardized oral challenge, referred to the Program of Formulas for Cow's Milk Allergy at a Pediatric University Hospital, in Natal, Rio Grande do Norte, Brazil (2007/2009). Clinical-epidemiological data and formula indication (soy, protein hydrolysates or aminoacid formula) were assessed at the first consultation. Clinical response and nutritional evolution (Anthro-OMS2006) were observed after three months. Chi-square and paired t-test were used, being p<0.05 significant. At the first consultation, mean age was 9.0±6.9 months. Digestive manifestations occurred in 81.8%; cutaneous ones, in 36.9% and respiratory ones in 23.8%. BMI Z-score <-2.0 standard deviations (SD) was found in 17.9% of children with isolated digestive symptoms, in 41.7% of those using cow's milk and in 8.7% of those using other formulas (p<0.01). The following formulas were used: soy in 61.2%, protein hydrolysates in 35.4% and aminoacids in 3.3%. Mean BMI Z-scores at initial consultation and after three months were, respectively: -0.24±1.47SD and 0.00±1.26SD (p=0.251), with soy formula, and -0.70±1.51SD and -0.14±1.36SD (p=0.322) with protein hydrolysates formula. Digestive manifestations of cow's milk allergy were preponderant, and lead to greater nutritional impairment. The use of replacement formulas (isolated soy protein and protein hydrolysates) was important to maintain the nutritional status.
    06/2013; 31(2):152-158. DOI:10.1590/S0103-05822013000200004
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Soybean [Glycine max (L.) Merr.] seed accumulates large amounts of isoflavones, which are known for their phytoestrogenic activities. Three isoflavones (genistein, daidzein, and glycitein) are found in the seed. They are 4 to 10 times more concentrated in hypocotyls than in cotyledons. Isoflavone composition markedly diverges between these two seed parts and their accumulation begins in cotyledons at 40 d after flowering (DAF) once completed in hypocotyls. The relation between the genes of the isoflavonoid pathway and the isoflavone content has been investigated through (i) the variability of isoflavone synthase (IFS) genomic sequences in six cultivars with contrasted isoflavone content and (ii) the expression of key genes in two cultivars at 25, 40, and 60 DAF in hypocotyls and cotyledons. IFS1 and IFS2 polymorphism was not related to the isoflavone content. The expression of chalcone synthases (CHS7 and CHS8) was related to isoflavone accumulation kinetics in the cotyledons but not with the total content at maturity. CHS9 was the most expressed CHS isoform and the only one correlated with the hypocotyl isoflavone accumulation kinetics. The chalcone reductase (CHR) and CHI expression profiles were significantly different between the two seed parts. These results indicate that the regulation of the isoflavone pathway is controlled differently in cotyledons and hypocotyls during seed maturation. This discrepancy should be taken into account in the studies on genetic and environmental effects on isoflavone contents.
    Crop Science 05/2013; 53(3-3):1096-1108. DOI:10.2135/cropsci2012.05.0267 · 1.48 Impact Factor

Preview

Download
0 Downloads
Available from